Your browser doesn't support javascript.
loading
Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies.
Mouabbi, Jason A; Raghavendra, Akshara Singareeka; Bassett, Roland L; Hassan, Amy; Tripathy, Debu; Layman, Rachel M.
Afiliación
  • Mouabbi JA; Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. jamouabbi@mdanderson.org.
  • Raghavendra AS; Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
  • Bassett RL; Department of Biostatistics, Unit 1411, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
  • Hassan A; Department of General Oncology, Unit 462, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
  • Tripathy D; Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
  • Layman RM; Department of Breast Medical Oncology, Unit 1354, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
NPJ Breast Cancer ; 8(1): 131, 2022 Dec 20.
Article en En | MEDLINE | ID: mdl-36539444
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: NPJ Breast Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: NPJ Breast Cancer Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos